Literature DB >> 18308373

Body composition and serum prostate-specific antigen: review and findings from Flint Men's Health Study.

Jennifer L Beebe-Dimmer1, Gary J Faerber, Hal Morgenstern, David Werny, Kirk Wojno, Bronwen Halstead-Nussloch, Kathleen A Cooney.   

Abstract

Recent studies have suggested that obesity is associated with lower serum prostate-specific antigen levels, perhaps influencing the recommendation for prostate biopsy and potentially explaining part of the observed poorer prognosis among obese men. African-American men have the greatest rates of prostate cancer and are more likely to die of the disease, making early detection a priority in this group. We present findings from the Flint Men's Health Study, a study of African-American men, that are consistent with most studies suggesting that overweight men have prostate-specific antigen levels that are 0.15 to 0.30 ng/mL lower than those who are not overweight. We have coupled our results with a systematic review of publications in this area.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18308373      PMCID: PMC2329814          DOI: 10.1016/j.urology.2007.11.049

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  43 in total

Review 1.  Economic costs of obesity and inactivity.

Authors:  G A Colditz
Journal:  Med Sci Sports Exerc       Date:  1999-11       Impact factor: 5.411

2.  The association between body size, prostate volume and prostate-specific antigen.

Authors:  J H Fowke; S S Motley; M S Cookson; R Concepcion; S S Chang; M L Wills; J A Smith
Journal:  Prostate Cancer Prostatic Dis       Date:  2006-12-19       Impact factor: 5.554

Review 3.  Obesity and prostate cancer: making sense out of apparently conflicting data.

Authors:  Stephen J Freedland; Elizabeth A Platz
Journal:  Epidemiol Rev       Date:  2007-05-03       Impact factor: 6.222

4.  Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.

Authors:  Carmen Rodriguez; Stephen J Freedland; Anusila Deka; Eric J Jacobs; Marjorie L McCullough; Alpa V Patel; Michael J Thun; Eugenia E Calle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-12-19       Impact factor: 4.254

5.  Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality.

Authors:  Margaret E Wright; Shih-Chen Chang; Arthur Schatzkin; Demetrius Albanes; Victor Kipnis; Traci Mouw; Paul Hurwitz; Albert Hollenbeck; Michael F Leitzmann
Journal:  Cancer       Date:  2007-02-15       Impact factor: 6.860

6.  Potential selection bias in a community-based study of PSA levels in African-American men.

Authors:  S G Heeringa; K H Alcser; K Doerr; M Strawderman; K Cooney; B Medbery; D Schottenfeld
Journal:  J Clin Epidemiol       Date:  2001-02       Impact factor: 6.437

7.  Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men.

Authors:  Jay H Fowke; Lisa B Signorello; Sam S Chang; Charles E Matthews; Maciej S Buchowski; Michael S Cookson; Flora M Ukoli; William J Blot
Journal:  Cancer       Date:  2006-11-15       Impact factor: 6.860

8.  Sensitivity and specificity of prostate-specific antigen for prostate cancer detection with high rates of biopsy verification.

Authors:  Donna Pauler Ankerst; Ian M Thompson
Journal:  Arch Ital Urol Androl       Date:  2006-12

9.  Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group.

Authors:  Stephen J Freedland; William J Aronson; Christopher J Kane; Joseph C Presti; Christopher L Amling; David Elashoff; Martha K Terris
Journal:  J Clin Oncol       Date:  2003-12-22       Impact factor: 44.544

Review 10.  Obesity and prostate cancer: epidemiology and clinical implications.

Authors:  W Cooper Buschemeyer; Stephen J Freedland
Journal:  Eur Urol       Date:  2007-05-02       Impact factor: 20.096

View more
  17 in total

1.  Body fat distribution on computed tomography imaging and prostate cancer risk and mortality in the AGES-Reykjavik study.

Authors:  Barbra A Dickerman; Johanna E Torfadottir; Unnur A Valdimarsdottir; Edward Giovannucci; Kathryn M Wilson; Thor Aspelund; Laufey Tryggvadottir; Lara G Sigurdardottir; Tamara B Harris; Lenore J Launer; Vilmundur Gudnason; Sarah C Markt; Lorelei A Mucci
Journal:  Cancer       Date:  2019-06-10       Impact factor: 6.860

Review 2.  Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer.

Authors:  A G Renehan; H-C Yeh; J A Johnson; S H Wild; E A M Gale; H Møller
Journal:  Diabetologia       Date:  2012-04-04       Impact factor: 10.122

3.  Serum prostate specific antigen changes in cynomolgus monkeys (Macaca fascicularis) on a high sugar high fat diet.

Authors:  James N Mubiru; Magdalena Garcia-Forey; Nicole Cavazos; Peggah Hemmat; Edward J Dick; Michael A Owston; Cassondra A Bauer; Robert E Shade; Jeffrey Rogers
Journal:  Prostate       Date:  2011-06-28       Impact factor: 4.104

4.  Substantial family history of prostate cancer in black men recruited for prostate cancer screening: results from the Prostate Cancer Risk Assessment Program.

Authors:  Kathleen Mastalski; Elliot J Coups; Karen Ruth; Susan Raysor; Veda N Giri
Journal:  Cancer       Date:  2008-11-01       Impact factor: 6.860

5.  The impact of obesity on the predictive accuracy of PSA in men undergoing prostate biopsy.

Authors:  Lionel L Bañez; Simone Albisinni; Stephen J Freedland; Andrea Tubaro; Cosimo De Nunzio
Journal:  World J Urol       Date:  2012-07-31       Impact factor: 4.226

6.  Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy.

Authors:  R Asmar; J L Beebe-Dimmer; K Korgavkar; G R Keele; K A Cooney
Journal:  Prostate Cancer Prostatic Dis       Date:  2012-08-21       Impact factor: 5.554

7.  Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans.

Authors:  J L Beebe-Dimmer; K A Zuhlke; A M Ray; E M Lange; K A Cooney
Journal:  Prostate Cancer Prostatic Dis       Date:  2010-08-10       Impact factor: 5.554

8.  Body mass index and prostate cancer severity: do obese men harbor more aggressive disease on prostate biopsy?

Authors:  Karim Chamie; Stephanie Oberfoell; Lorna Kwan; Jessica Labo; John T Wei; Mark S Litwin
Journal:  Urology       Date:  2013-03-07       Impact factor: 2.649

9.  Is there a role for body mass index in the assessment of prostate cancer risk on biopsy?

Authors:  Yuanyuan Liang; Norma S Ketchum; Phyllis J Goodman; Eric A Klein; Ian M Thompson
Journal:  J Urol       Date:  2014-04-18       Impact factor: 7.450

10.  A Review on the Clinical Utility of PSA in Cancer Prostate.

Authors:  Mohan Adhyam; Anish Kumar Gupta
Journal:  Indian J Surg Oncol       Date:  2012-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.